about
Has patient survival following renal transplantation improved in the era of modern immunosuppression?Poly[ADP-ribose] polymerase-1 expression is related to cold ischemia, acute tubular necrosis, and delayed renal function in kidney transplantation.Estimation of renal allograft half-life: fact or fiction?Hypertension in chronic kidney disease: the influence of renal transplantation.Preservation of renal function during maintenance therapy with cyclosporine.High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.Unmasking glucose metabolism alterations in stable renal transplant recipients: a multicenter study.Comparison of the long-term outcomes of kidney transplantation: USA versus Spain.Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.Chronic renal allograft damage: existing challenges.Innate immunity in renal transplantation: the role of mannose-binding lectin.Native ureteropyelostomy in the treatment of obstructive uropathy in adult renal transplant. Experience and technical alternatives.Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.Renal transplant outcomes in Spain.Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients.Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case-control study.Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies.[Chronic transplant nephropathy].Total glomerular number in stable renal allografts.Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts.Structural and functional correlations in stable renal allografts.Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules.Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies.Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.Baseline immunosuppression is associated with histological findings in early protocol biopsies.Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation.Low serum mannose-binding lectin are associated with inflammation, new-onset diabetes mellitus and subclinical rejection after renal transplantation.[Post-transplant diabetes mellitus depending on the pre-transplant dialysis technique]Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study.Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.Glomerular size in early protocol biopsies is associated with graft outcome.Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.Poly(ADP-ribose) polymerase expression in kidney transplantation: from alfa (alpha) to Omega (Omega).Donor structural and functional parameters are independent predictors of renal function at 3 months.
P50
Q26830083-C7B59E99-FE3E-4DAC-B7EC-227BB7DD0DF5Q33507083-7EC5DB20-C26A-4835-9CE2-383325623A16Q33811582-583F65E8-1D63-4943-A8D0-95962E4FD65AQ35158254-32287B18-CE6B-41AD-934B-6A92CE4CE921Q35711170-5307C157-1659-4E58-8172-0A7F18764E3BQ36638382-A3642AA2-41AD-4E64-8948-17B46C863AEEQ36662045-D25685E7-F165-4323-9F34-1E34A8312054Q36740996-318BEA08-55BA-4729-ADD3-69E485041539Q36906015-E1295F29-B664-44EE-BDAF-F378E0B0A391Q37868857-2E839629-DCE4-4FE7-80B3-0669660E0AA5Q38169834-8779536A-8B43-4514-ABD5-0647922FC276Q38196502-BCE238FF-4F6E-4086-B723-AB868023D9F3Q38699017-12CB43B0-90AB-40F8-9625-2DF6821BAF5AQ40704830-C622BFA8-1718-4DFE-AFD6-22EDEA2E1DD5Q42166284-28536376-E632-4CD1-883A-9D7CF5836DC1Q43129316-70811EF9-A51E-4F80-AA58-0D64713EDEEBQ43889585-6B040F77-82BF-43BC-AEAE-D8AC3AF57A33Q43944571-937DC2A8-9441-4FB7-94FF-748011314E17Q43963150-F0393544-61F1-46F5-BB64-2C64D04753C0Q44048416-93650003-D235-4258-86F5-1B4CBAB13070Q44423499-AB00328D-2978-42E0-BB84-B3842CA3F38DQ44577525-208B82DE-394F-476A-A74B-2836069D3069Q44577578-6C00FD9A-BE3C-4375-8AC6-C0F68DC95A19Q44800868-CE6384E3-9BFF-425E-B530-3E2E3D02E295Q44976410-E8803138-975C-459A-9954-49F409BDD76BQ45103459-3A28D19B-F513-496D-9D8D-2D5A1D84902FQ45421182-A686B643-1AD2-47F5-869C-D1209DAD5D4DQ45923642-11A150CF-BB6D-449E-AA86-F619ABDFB16AQ46089969-6C6E08B5-86A1-46E0-8679-0110B8FC7E42Q46289686-D45FAF34-9275-440D-82EC-C4256AE6AEB3Q46486899-CF52ACDF-8FC3-4CF2-AB15-84F67AD381AFQ46631003-FB87B9AA-9379-42C8-9C36-66C002E404CFQ46632322-F7273F4F-81B6-407B-A85A-9B5D5DBB676FQ46816094-8405892A-6357-42B0-95A6-976A1F70FB6EQ46873864-FE4B471F-25D9-4C7A-8AA6-4A024E29ED08Q46873896-88BF27E4-754D-4AF1-9CDB-636110EF115DQ46913380-98FFDB06-012B-40A7-9942-8F82DC2AEE64Q46986738-8C14B951-9134-4E27-8DBB-E0AD0DCC3E54Q46986793-B65AA023-47BF-4A95-998B-4DE9DB4EB6B4Q46986794-AB89F713-3AEB-4B2A-B2D1-BA3111EBEDDF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesc Moreso
@ast
Francesc Moreso
@en
Francesc Moreso
@es
Francesc Moreso
@nl
Francesc Moreso
@sl
type
label
Francesc Moreso
@ast
Francesc Moreso
@en
Francesc Moreso
@es
Francesc Moreso
@nl
Francesc Moreso
@sl
prefLabel
Francesc Moreso
@ast
Francesc Moreso
@en
Francesc Moreso
@es
Francesc Moreso
@nl
Francesc Moreso
@sl
P106
P21
P31
P496
0000-0002-7267-3963